EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 47 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,063,333 | -26.1% | 360,093 | 0.0% | 0.02% | -27.3% |
| Q2 2023 | $2,790,721 | +16.2% | 360,093 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $2,401,820 | -25.4% | 360,093 | +0.0% | 0.03% | -23.3% |
| Q4 2022 | $3,219,214 | -39.4% | 360,091 | -33.3% | 0.04% | -41.9% |
| Q3 2022 | $5,312,000 | -13.5% | 539,864 | -30.1% | 0.07% | -22.1% |
| Q2 2022 | $6,144,000 | +75.9% | 771,797 | +114.3% | 0.10% | +66.7% |
| Q1 2022 | $3,493,000 | -43.3% | 360,093 | -10.6% | 0.06% | -35.2% |
| Q4 2021 | $6,156,000 | +2.5% | 402,849 | +11.3% | 0.09% | -10.2% |
| Q3 2021 | $6,006,000 | -20.6% | 361,821 | +2.1% | 0.10% | -30.5% |
| Q2 2021 | $7,561,000 | -34.9% | 354,489 | -0.8% | 0.14% | -45.3% |
| Q1 2021 | $11,616,000 | – | 357,429 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |